Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The ocular surface epithelial glycocalyx is a specialized extracellular matrix layer composed primarily of membrane-associated mucins (MUC1, MUC4, and MUC16) and glycoproteins that coat the apical surface of the corneal and conjunctival epithelium (Gipson, 2011, PMID: 21705598). This structure serves as a critical interface between the ocular surface and the tear film, providing lubrication, maintaining hydration, and acting as a physical and chemical barrier against pathogens and environmental insults (Mantelli & Argüeso, 2008, PMID: 18435583). In pathological conditions such as dry eye disease, the glycocalyx is often degraded or diminished, leading to increased friction, inflammation, and epithelial damage (Uchino et al., 2013, PMID: 23554833). Therapeutic strategies aim to restore this layer through the use of mucin secretagogues, such as rebamipide and diquafosol, or by applying mucomimetic agents like hyaluronic acid that stabilize the tear film (Kinoshita et al., 2013, PMID: 23307496). Understanding the glycocalyx is essential for developing treatments that address the underlying causes of ocular surface instability and discomfort.
Stimulation of mucin secretion from epithelial cells and goblet cells, stabilization of the tear film-epithelial interface, and restoration of the protective barrier (Koh et al., 2013, PMID: 23444345).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ocular surface epithelial glycocalyx.